Roselabs Bioscience Private Limited

Roselabs Biosciences have a state-of-the-art manufacturing facility which is built to meet the specifications of US-FDA and other international regulatory bodies. Roselabs Group has invested over USD 102 million in this uniquely interesting venture. Prefilled syringe is an important primary drug container to both biotechnology and pharmaceutical companies. There are only a very few companies. The demand is increasing exponentially. Roselabs have geared up for this.